Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1 lab Model of Dravet Syndrome.

(Grone B, et al. 2017). Anti-epileptic drug (AED) screening in zebrafish has proven efficient in models of Dravet syndrome due to the lower cost of maintaining fish compared with mouse colonies and rapid reproduction rates. The zebrafish used to study Dravet syndrome carry mutations in scn1lab (a zebrafish version of the human SCN1A gene) and are …

Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1 lab Model of Dravet Syndrome. Read More »